KIC 华盛顿特区 Accelerator Collaborates with MassChallenge
Five companies to participate in Bio iCORE Program through 2023
https://www.hellodd.com/news/articleView.html?idxno=95343
The Bio iCORE program includes five companies selected as final global 初创企业 teams — NeuroEars, STEMDEN, RudaCure, and two others — and will run through March 2023.MassChallenge prioritizes public benefit and the advancement of human welfare alongside profitability, and does not require equity or management rights from 初创企业s. This program is a collaboration between KIC DC and MassChallenge, providing promising 韩国 bio-tech companies with opportunities to meet global entrepreneurs, investors, and technology experts. It aims to support the successful 全球拓展 of outstanding 韩国 bio 初创企业s through education, training, and mentoring.